|
"tung ys"的相關文件
顯示項目 1-8 / 8 (共1頁)
1
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2011-11 |
Reducing lesion aberration by dual-frequency focused ultrasound ablations
|
Chen, WS;Liu, HL;Tung, YS;Wang, JC;Ding, YH;Jan, CK |
| 國家衛生研究院 |
2011-04-28 |
Scaffold-hopping strategy: Synthesis and biological evaluation of 5,6-Fused bicyclic heteroaromatics to identify orally bioavailable anticancer agents
|
Tung, YS;Coumar, MS;Wu, YS;Shiao, HY;Chang, JY;Liou, JP;Shukla, P;Chang, CW;Chang, CY;Kuo, CC;Yeh, TK;Lin, CY;Wu, JS;Wu, SY;Liao, CC;Hsieh, HP |
| 國家衛生研究院 |
2010-12-01 |
抗肿瘤化合物
|
Hsieh, HP;Chao, YS;Liou, JP;Chang, JY;Tung, YS |
| 國家衛生研究院 |
2008-11-25 |
Anti-tumor compounds
|
Hsieh, HP;Chao, YS;Liou, JP;Chang, JY;Tung, YS |
| 國家衛生研究院 |
2008-09-11 |
Bioisosteric replacement of the pyrazole 5-aryl moiety of N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A). A novel series of alkynylthiophenes as potent and selective cannabinoid-1 receptor antagonists
|
Tseng, SL;Hung, MS;Chang, CP;Song, JS;Tai, CL;Chiu, HH;Hsieh, WP;Lin, Y;Chung, WL;Kuo, CW;Wu, CH;Chu, CM;Tung, YS;Chao, YS;Shia, KS |
| 國家衛生研究院 |
2008-05-01 |
抗腫瘤化合物
|
Hsieh, HP;Liou, JP;Chang, JY;Tung, YS;Chao, YS |
| 國家衛生研究院 |
2006-10 |
Structure-activity relationship studies of 3-aroylindoles as potent antimitotic agents
|
Liou, JP;Mahindroo, N;Chang, CW;Guo, FM;Lee, SWH;Tan, UK;Yeh, TK;Kuo, CC;Chang, YW;Lu, PH;Tung, YS;Lin, KT;Chang, JY;Hsieh, HP |
| 臺北醫學大學 |
2006 |
Structure-Activity Relationship Studies of 3-Aroylindoles as Potent Antimitotic Agents
|
劉景平; Liou JP; Mahindroo N; Chang CW; Guo FM; Lee SW; Yeh TK; Tan UK; Kuo CC; Chang YW; Lu PH; Tung YS; |
顯示項目 1-8 / 8 (共1頁)
1
每頁顯示[10|25|50]項目
|
